Rahul Kumar

Induction of whole-body gene deletion via R26-regulated tamoxifen-inducible Cre recombinase activity

Y. Saini, S. Patial, Yun Mao, 2022, Frontiers in Pharmacology.

E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer.

A. Ashworth, M. Dowsett, A. Tutt, 2018, Cancer discovery.

Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells

A. Ashworth, S. Pettitt, C. Lord, 2017, British Journal of Cancer.

Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancer

Colm J. Ryan, S. Pettitt, C. Lord, 2018, Oncogene.

Analysis of single-nucleotide polymorphisms in genes associated with triple-negative breast cancer

A. Eranki, Q. Hasan, V. G., 2022, Frontiers in Genetics.

Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma

A. Saraya, S. Gamanagatti, N. Dash, 2023, Frontiers in genetics.

Assessing germline mutational profile and its clinicopathological associations in Triple Negative Breast Cancer

Sanket, R. Sabarinathan, D. Kelkar, 2022, medRxiv.